Farringdon Capital’s Balchem Corp BCPC Stock Holding History

Farringdon Capital’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-2,559	Closed	-$417K	–	639
2024 Q4	$417K	Buy	+2,559	New	+$444K	0.17%	170

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farringdon Capital's BCPC Position: Q1 2025 in Review

Farringdon Capital sold out of Balchem Corp (BCPC) in Q1 2025, closing a stake of 2,559 shares — an estimated $417K sold.

Farringdon Capital first reported a position in BCPC in Q4 2024 and held it in 1 quarter. The position peaked at $417K in Q4 2024. 382 funds tracked by Wall St. Rank hold BCPC as of Q1 2025.

Farringdon Capital reported no remaining Balchem Corp position as of Q1 2025 after selling out during the quarter.
Farringdon Capital sold 2,559 Balchem Corp shares in Q1 2025, an estimated $417K.
Farringdon Capital first reported a position in Balchem Corp in Q4 2024 and held it in 1 quarter.
Farringdon Capital's Balchem Corp position peaked at $417K in Q4 2024.
382 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2025.

Based on Farringdon Capital's 13F filing for Q1 2025, filed 15 May 2025.